# Daidzin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/daidzin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Daidzein 7-O-glucoside, Daidzein 7-glucoside, 7-Glucosyldaidzein, Daidzein-7-O-β-D-glucopyranoside, Soy isoflavone glycoside, 4',7-Dihydroxyisoflavone 7-glucoside

## Overview

Daidzin is an isoflavonoid glycoside found primarily in soybeans and kudzu root, where it serves as the glucoside precursor to the active aglycone daidzein. It exerts its primary effects through selective estrogen receptor modulation (SERM activity) and inhibition of aldehyde dehydrogenase-2 (ALDH2), influencing both hormonal and metabolic pathways.

## Health Benefits

• May support [bone health](/ingredients/condition/bone-health) through osteoblast stimulation (mechanism studies only, no significant clinical effects shown in 6-month RCT)
• Potential [cardiovascular](/ingredients/condition/heart-health) protection via [antioxidant](/ingredients/condition/antioxidant) pathways (no significant effects on lipid profiles in 24-week RCT, n=165, PMID: 34263280)
• Possible menopausal symptom relief through estrogen receptor modulation (no significant effects in 6-month RCT, n=270)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects via NF-κB inhibition (preclinical evidence only)
• [Neuroprotective](/ingredients/condition/cognitive) potential in Alzheimer's/Parkinson's models (preclinical evidence only)

## Mechanism of Action

Daidzin is hydrolyzed by intestinal beta-glucosidases into daidzein, which binds preferentially to estrogen receptor beta (ERβ) with approximately 100-fold greater affinity than ERα, modulating estrogen-responsive gene expression. Daidzein is further metabolized by gut microbiota into equol, a more potent phytoestrogen whose production varies significantly between individuals based on [microbiome](/ingredients/condition/gut-health) composition. Additionally, daidzin directly inhibits [mitochondrial](/ingredients/condition/energy) aldehyde dehydrogenase-2 (ALDH2), an enzyme involved in acetaldehyde [metabolism](/ingredients/condition/weight-management), which underpins research into its effects on alcohol aversion and [dopamine pathway](/ingredients/condition/mood) modulation.

## Clinical Summary

A 24-week randomized controlled trial (n=165, PMID: 34263280) examining [cardiovascular](/ingredients/condition/heart-health) endpoints found no significant effects on LDL, HDL, or total cholesterol in adults supplementing with daidzin-containing isoflavone extracts. A 6-month RCT investigating [bone mineral density](/ingredients/condition/bone-health) found that daidzin stimulated osteoblast activity in mechanistic assays but failed to produce statistically significant improvements in clinical bone density measures. Evidence for menopausal symptom relief is mixed; benefits appear largely confined to equol-producer phenotypes, estimated at 25–30% of Western populations and 50–60% of Asian populations. Overall, the clinical evidence base for daidzin specifically remains limited, with most positive outcomes derived from in vitro, animal, or surrogate-endpoint studies.

## Nutritional Profile

Daidzin is a pure isoflavone glycoside compound (molecular formula C21H20O9, molecular weight 416.38 g/mol), not a whole food, and therefore contains no macronutrients, fiber, vitamins, or minerals in isolation. As a bioactive compound, it is classified as a phytoestrogen belonging to the isoflavone subclass. Daidzin is the 7-O-glucoside conjugate of the aglycone daidzein, naturally occurring in soybeans (Glycine max) at approximately 0.5–1.5 mg/g dry weight, and in other legumes such as kudzu root (Pueraria lobata) at concentrations up to 1.0–2.0 mg/g dry weight. Upon ingestion, intestinal glucosidases and gut microbiota cleave the glucose moiety to release the active aglycone daidzein, which is further metabolized to equol (in approximately 25–30% of Western adults and ~50–60% of Asian adults who harbor the necessary gut bacteria) or O-desmethylangolensin. Bioavailability of daidzin is estimated at 13–35% relative to the aglycone form, with the glycoside form showing slower but more sustained absorption compared to daidzein. Peak plasma concentrations following a typical soy-containing meal are reported in the range of 0.5–1.5 µmol/L. Daidzin exhibits moderate estrogenic activity (relative binding affinity to ERβ approximately 0.1% compared to 17β-estradiol) and [antioxidant activity](/ingredients/condition/antioxidant) with an ORAC value estimated in vitro, though in vivo antioxidant clinical translation remains unconfirmed. No caloric contribution is applicable in supplemental form.

## Dosage & Preparation

Clinically studied doses of daidzein (the active metabolite of daidzin) range from 50-63 mg/day, typically administered with soy protein or milk powder for 24-26 weeks. No specific dosing established for daidzin itself. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Daidzin is generally well tolerated in food amounts and typical supplement doses (40–80 mg isoflavone equivalent daily), with mild gastrointestinal discomfort being the most commonly reported adverse effect. Due to its ERβ agonist activity, daidzin supplementation is considered potentially contraindicated in individuals with estrogen receptor-positive cancers, and it should be used with caution alongside tamoxifen or aromatase inhibitors due to potential pharmacodynamic interactions. It may also interact with warfarin by modestly inhibiting CYP2C9-mediated [metabolism](/ingredients/condition/weight-management), warranting INR monitoring in anticoagulated patients. Pregnant and breastfeeding women are advised to avoid supplemental doses beyond dietary intake, as neonatal exposure to phytoestrogens raises unresolved developmental safety questions.

## Scientific Research

Clinical evidence for daidzin is limited, with most trials studying its metabolite daidzein. A 24-week RCT (n=165, PMID: 34263280) found no significant effects on lipid profiles or [inflammation](/ingredients/condition/inflammation) markers with 50mg daidzein daily. A 6-month RCT in 270 postmenopausal women (NCT01270737) showed no benefits for [blood pressure](/ingredients/condition/heart-health), menopausal symptoms, or bone [metabolism](/ingredients/condition/weight-management) with 63mg purified daidzein daily.

## Historical & Cultural Context

While isolated daidzin has no traditional use history, soy-based foods containing isoflavones have been used in Traditional Chinese Medicine for millennia, particularly for women's health and [hormonal balance](/ingredients/condition/hormonal). Modern research on purified compounds builds upon the historical dietary role of whole soy foods in Asian cultures.

## Synergistic Combinations

Soy protein, genistein, glycitein, calcium, vitamin D

## Frequently Asked Questions

### What is daidzin and how is it different from daidzein?

Daidzin is the glycoside form of daidzein, meaning it has a glucose molecule attached at the 7-hydroxyl position that must be cleaved by intestinal beta-glucosidases before absorption. Daidzein, the resulting aglycone, is the biologically active form that binds estrogen receptors and undergoes further gut microbial conversion to equol. This hydrolysis step means daidzin has slower absorption kinetics than daidzein but is the predominant form found naturally in whole soybeans.

### Does daidzin help with menopause symptoms?

Clinical evidence is modest and highly dependent on whether a person can metabolize daidzein into equol via gut bacteria, since equol is the more potent ERβ agonist responsible for most phytoestrogenic activity. Studies in equol-producer populations show modest reductions in hot flash frequency, while non-producers show little benefit. A typical isoflavone dose studied for menopausal symptoms ranges from 40–80 mg per day of total isoflavones over 12–24 weeks, with effects generally smaller than low-dose hormone therapy.

### Can daidzin help reduce alcohol cravings?

Daidzin inhibits mitochondrial aldehyde dehydrogenase-2 (ALDH2), causing accumulation of acetaldehyde following alcohol consumption, which produces aversive effects similar in principle to disulfiram. Preclinical studies in Syrian golden hamsters showed significant reductions in voluntary alcohol intake at doses approximating 100 mg/kg. Human clinical trials are limited and have not yet established an effective dose or confirmed efficacy, so this application remains investigational.

### What foods are highest in daidzin?

Soybeans and soy-based foods are by far the richest dietary sources of daidzin, with raw soybeans containing approximately 56–90 mg of daidzin per 100 g dry weight. Fermented soy products like tempeh and miso contain less daidzin and more free daidzein because fermentation promotes glycoside hydrolysis. Kudzu root (Pueraria lobata) is another significant source, used in traditional East Asian medicine, and contains daidzin alongside the related isoflavone puerarin.

### Is daidzin safe for people with thyroid conditions?

Isoflavones including daidzin can inhibit thyroid peroxidase (TPO), the enzyme central to thyroid hormone synthesis, raising concerns for individuals with hypothyroidism or those taking levothyroxine. Population studies suggest dietary soy isoflavone intake does not significantly affect thyroid function in iodine-sufficient individuals with intact thyroid glands. However, individuals with Hashimoto's thyroiditis or existing subclinical hypothyroidism are generally advised to separate levothyroxine and soy supplement doses by at least 4 hours and monitor TSH levels when initiating supplementation.

### How much daidzin should I take daily, and does timing matter?

There is no established clinical dosage for daidzin supplementation, as most research has used doses ranging from 40–150 mg daily without establishing efficacy standards. Timing relative to meals may affect absorption since daidzin is a glucoside that requires gut bacterial conversion to the more bioavailable aglycone form (daidzein), but research has not identified an optimal timing protocol. It is advisable to consult a healthcare provider before beginning supplementation, as individual absorption and metabolism vary considerably.

### Can daidzin interact with hormone replacement therapy or birth control medications?

Daidzin acts as a selective estrogen receptor modulator (SERM), which theoretically could interact with hormone-based medications such as HRT or oral contraceptives by competing for receptor binding or altering estrogen metabolism. However, direct clinical interaction studies between daidzin and these medications have not been conducted. Anyone taking hormone-based medications should consult their physician before adding daidzin supplementation to avoid potential interference with treatment efficacy.

### What does the clinical research actually show about daidzin's effectiveness?

Recent clinical trials show limited positive results: a 6-month RCT (n=270) found no significant effects on menopausal symptoms despite theoretical estrogen-modulating pathways, and a 24-week cardiovascular study (n=165, PMID: 34263280) showed no meaningful improvements in lipid profiles. While laboratory studies suggest daidzin may stimulate bone-building cells (osteoblasts), no significant clinical bone health outcomes have been demonstrated in human trials. The current evidence base does not support strong claims of clinical efficacy for daidzin supplementation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*